Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cell & Gene Therapy
Pharma
Thermo Fisher to cut 160 jobs amid viral vector overhaul
In a bid to streamline viral vector manufacturing, Thermo Fisher is charting another round of layoffs—and closing a U.S. factory along the way.
Fraiser Kansteiner
Nov 11, 2024 2:48pm
Autolus enters CAR-T race with FDA approval for Aucatzyl
Nov 11, 2024 11:30am
CDMO Avid to go private in $1.1B deal
Nov 7, 2024 2:50pm
Gilead's CAR-T sales stagnate as Trodelvy takes another write-off
Nov 7, 2024 11:16am
AGC Bio embarks on turnaround strategy under new CEO
Nov 7, 2024 10:10am
FDA revisits CAR-T boxed warning on secondary cancers: Marks
Nov 1, 2024 10:30am
More News
Roche's Vabysmo will rise above Eylea biosim threat, exec says
Oct 23, 2024 11:24am
Legend sheds GenScript as its majority shareholder
Oct 23, 2024 7:26am
Canadian CDMO OmniaBio debuts new cell and gene therapy facility
Oct 17, 2024 9:25am
AstraZeneca-CSPC, Astellas and more—Fierce Pharma Asia
Oct 11, 2024 9:48am
See more stories
